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Abstract
Background: Chlamydia and gonorrhoea are major causes of morbidity among women in developing countries.
Both infections have been associated with pregnancy-related complications, and case detection and treatment in
pregnancy is essential. In countries without laboratory support, the diagnosis and treatment of cervical infections
is based on the syndromic approach. In this study we measured the prevalence of chlamydia and gonorrhoea
among antenatal care attendees in Botswana. We evaluated the syndromic approach for the detection of cervical
infections in pregnancy, and determined if risk scores could improve the diagnostic accuracy.
Methods: In a cross-sectional study, 703 antenatal care attendees in Botswana were interviewed and examined,
and specimens were collected for the identification of C trachomatis, N gonorrhoeae and other reproductive tract
infections. Risk scores to identify attendees with cervical infections were computed based on identified risk
factors, and their sensitivities, specificities, likelihood ratios and predictive values were calculated.
Results: The prevalence of chlamydia was 8%, and gonorrhoea was found in 3% of the attendees. Symptoms and
signs of vaginal discharge did not predict cervical infection, and a syndromic approach failed to identify infected
women. Age (youth) risk factor most strongly associated with cervical infection. A risk score with only
sociodemographic factors had likelihood ratios equivalent to risk scores which incorporated clinical signs and
microscopy results. However, all the evaluated risk scores were of limited value in the diagnosis of chlamydia and
gonorrhoea. A cut-off set at an acceptable sensitivity to avoid infected antenatal care attendees who remained
untreated would inevitably lead to considerable over-treatment.
Conclusion: Although in extensive use, the syndromic approach is unsuitable for diagnosing cervical infections
in antenatal care attendees in Botswana. None of the evaluated risk scores can replace this management. Without
diagnostic tests, there are no adequate management strategies for C trachomatis and N gonorrhoeae in pregnant
women in Botswana, a situation which is likely to apply to other countries in sub-Saharan Africa. Screening for
cervical infections in pregnant women is an essential public health measure, and rapid tests will hopefully be
available in developing countries within a few years.
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Background
Sub-Saharan Africa has the highest prevalence of gonor-
rhoea and chlamydia worldwide. These two sexually
transmitted infections (STIs) have a major impact on
health, particularly in women and neonates [1]. A cervical
infection with Neisseria gonorrhoeae or Chlamydia trachom-
atis can cause serious complications, such as ascending
infections, infertility, cervical cancer, spontaneous abor-
tion, premature delivery and low birth weight [2]. Epide-
miological and biological studies have shown that
ulcerative and non-ulcerative STIs can enhance HIV trans-
mission [3,4].
It should be part of the mandate of the antenatal care pro-
grammes to diagnose and treat C trachomatis and N gonor-
rhoeae, due to their association with maternal, foetal and
infant morbidity. In developing countries, diagnosis of
cervical infections is limited to the syndromic approach,
using the 'vaginal discharge syndrome' (VDS) algorithm.
In the early 1990s, the World Health Organization devel-
oped syndromic management guidelines as a case man-
agement of symptomatic STI patients in countries without
laboratory support [5]. Easily recognized symptoms and
signs are combined using flowcharts, and patients are
treated with two or more antibiotic regimens to cover the
majority of, or the most serious, organisms responsible
for producing a syndrome. The VDS algorithm for the
management of vaginal and cervical infections is far from
ideal, and for chlamydia or gonorrhea, this simplified
approach is neither sensitive nor specific [2,5-8]. Simple,
rapid tests for these infections have been requested for
more than a decade [9,10], and the continued use of the
syndromic approach in the management of cervicitis has
been viewed as a temporary solution while awaiting the
development of such tests [11].
The majority of women with a cervical infection are
asymptomatic [12] and their infection will not be
detected by the syndromic approach. As screening with
specific diagnostic tests have been out of reach, risk scores
based on sociodemographic risk factors, symptoms or
signs of infection, urine sticks and microscopy have been
explored as screening tools to identify asymptomatic
infections among pregnant women. Studies from sub-
Saharan countries have shown variable and unconvincing
results [9,10,13-16].
It has become clear that vaginal discharge is poorly predic-
tive of cervicitis, and in order to reduce over-treatment,
the WHO recommends the incorporation of risk assess-
ments in the syndromic management of cervical infec-
tions [5]. In Botswana, the syndromic approach has
recently been revised, and lower abdominal pain was
included as a second entry symptom in the VDS algorithm
[17]. Treatment for C trachomatis and N gonorrhoeae is
reserved for women who present with vaginal discharge or
lower abdominal pain and  have either a positive risk
assessment (age less than 21 years or complaints of yellow
discharge) or yellow discharge or cervical mucopus on
examination. These new recommendations are based on a
non-validated study of female STI patients [18]. Risk fac-
tors' association with infection is specific to the popula-
tion group from which they are extracted [5,13], and a
validation of the algorithm in the antenatal care is lacking.
There are two parallel strategies to manage reproductive
tract infections (RTIs) in pregnancy in Botswana. In addi-
tion to the syndromic management of women with symp-
toms, all antenatal care attendees are clinically screened
for RTIs. The antenatal care guidelines recommend a rou-
tine speculum examination at the first antenatal visit, to
"exclude genital infections, abnormalities and pelvic
tumours" [19]. It is not uncommon for abnormal vaginal
discharge to be found in women who are not eliciting
symptoms. Asymptomatic pregnant women with signs of
vaginal discharge will also be provided with syndromic
treatment. Clinical screening bypasses the original entry
point of the syndromic algorithms: symptoms which lead
to health-care seeking, and it is not within the WHO rec-
ommendations.
The aim of this study was to determine the prevalence of
C trachomatis and  N gonorrhoeae among antenatal care
attendees in Botswana, and to assess the validity of the
'vaginal discharge syndrome and lower abdominal pain'
algorithm in the diagnosis of cervicitis in pregnancy. We
also evaluated the diagnostic accuracy of risk scores based
on sociodemographic factors, specific symptoms or signs,
or microscopy. The results from Botswana are used to dis-
cuss the management of cervicitis in pregnancy in sub-
Saharan Africa.
Methods
Participating in this study were 703 pregnant women who
visited the 13 main facilities providing antenatal care in
Gaborone, Botswana: 12 primary health clinics and one
outpatient department. A proportionate sample of attend-
ees was recruited from each location. This proportion cor-
responded to the percentage of all antenatal care attendees
in Gaborone who visited that facility during the previous
year. Facilities were visited one-by-one by a medical doc-
tor between October 2000 and February 2001. In the
majority of clinics, all attendees were included in the
study. In the busiest clinics, only a sample of the attendees
was included; the selection of attendees in these clinics
was incidental. Approximately one out of every four ante-
natal care attendees in Gaborone was included in the
study during the period of data collection. All participants
gave written, informed consent. The only exclusion crite-BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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rion was the use of antibiotics during the previous two
weeks.
A structured interview and information from the patient-
held antenatal record were used to obtain data on socio-
demographic and behavioural factors, current RTI symp-
toms, and diagnosis and prescribed treatment for such
conditions earlier in the pregnancy. All patients under-
went a genital examination; appropriate specimens were
collected; and abnormal signs from external and internal
genitalia were recorded in detail.
Laboratory analyses
Urine was checked on site with a dipstick; all other speci-
mens were analysed at the National Health Laboratory in
Gaborone. Cervical swabs were obtained for ligase chain
reaction (LCR) amplification technology for detection of
C trachomatis and N gonorrhoeae. The swabs were placed in
LCx® transport media, transported to the laboratory the
same day, and stored at -20°C prior to batch processing.
The LCx® Assays (Abbott Laboratories, IL) were performed
according to the manufacturer's instructions. A case of C
trachomatis or N gonorrhoeae infection was defined as an
individual with a positive LCR analysis.
A high vaginal swab for identification of Trichomonas vag-
inalis was placed in Stuart transport media. Before cultur-
ing, a wet-mount was made and examined for the
presence of motile trichomonads by light microscopy,
100 × magnification. The swab was then agitated into a
bottle of Diamond's modified medium. The bottles were
incubated with indicators in Oxoid gaspack jars (3.4 litres,
with anaerobic system BR 038B). Wet-mounts from the
cultures were examined once a day for five days by light
microscopy.
Gram-stained vaginal smears were scored for bacterial
vaginosis according to Nugent's criteria [20]. Culture of
Candida species was initiated by direct inoculation of a
high vaginal swab on Saboraud plates on site, and Gram-
stained smears and wet-mounts from high vaginal swabs
were examined for budding yeast cells and pseudohyphae.
A cervical smear was gram-stained to count polymorpho-
nuclear leukocytes per high power field (PMN/HPF).
Statistical analyses and risk scores
Data were analysed with the statistical package SPSS Ver-
sion 11. We performed univariate analyses on all inde-
pendent variables in our dataset which could be
associated with cervical infection. The factors were within
four categories: sociodemographic and behavioural fac-
tors, symptoms, clinical signs, and microscopy results.
The dependent variable "cervicitis" was defined as infec-
tion with C trachomatis or N gonorrhoeae, or both. Factors
which in the univariate analysis were associated with
infection at a 0.2 level (p-value of odds ratio (OR)) were
included in multiple logistic regression analyses. We per-
formed multiple logistic regression analyses on sociode-
mographic factors, symptoms, clinical signs and
laboratory results, separately and combined. Due to the
high number of variables, the full analysis of different fac-
tors' independent association with cervicitis had to be per-
formed in two steps. First, multiple logistic regression
analyses for the four variable categories were performed
separately. The analysis was then extended to combining
the factors from the different categories which were signif-
icantly independently associated with cervical infection in
the first step.
Three levels of risk scores were computed and retrospec-
tively applied, and each of them were assessed for their
usefulness as a diagnostic tool to manage N gonorrhoeae
and C trachomatis infections in the antenatal care. The first
risk score level consists of only sociodemographic factors.
At the second risk score level we added findings from the
gynaecological examination. At the third level, we also
allowed the results from microscopy of vaginal and cervi-
cal smears. Microscopy can be done on site, and thus all
three risk score levels – the sociodemographic, the clinical
and the microscopy score – can theoretically be per-
formed during an antenatal care visit. The weights for each
factor used in the risk scores were based on correspondent
multiple logistic regression analysis models. The log of the
OR for the variables in the model multiplied by 10 and
rounded to the nearest whole number were used as
weights for the respective factors in the risk scores [9]. The
factors included and their respective weights are shown
for each risk score in Table 1.
Receiver Operating Characteristic (ROC) curves were used
to compare the different risk scores. The ROC curve shows
the sensitivity and specificity that correspond to each pos-
sible cut-off for the risk score. The validity of different
diagnostic strategies (the existing STI management guide-
lines, diagnosis based on symptoms or signs alone, and
diagnosis based on a risk score) was assessed by measur-
ing sensitivity, specificity, positive and negative likelihood
ratios (LR+ and LR-) and positive and negative predictive
values (PPV and NPV). The LCR-based laboratory diagno-
sis of cervical infection was used as the reference standard.
In the evaluation and comparison of diagnostic strategies,
we present two cut-offs for the risk scores, taken at a sen-
sitivity of minimum 0.40 and 0.70.
The study was approved by ethical committees in Bot-
swana and in Norway.
Results
Of the 703 women, 67 (10%) had laboratory-confirmed
cervical infection: 51 (8%) were infected with C trachoma-BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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tis, and 21 (3%) with N gonorrhoea. T vaginalis was identi-
fied in 131 (19%) women and bacterial vaginosis in 268
(38%) women. Candida species were identified by micro-
scopy and/or culture in 416 (59%) of the women. A total
of 561 (80%) of the antenatal care attendees had one or
more of these five reproductive tract infections.
Subjective symptoms and clinical signs
In spite of the high prevalence of cervical and vaginal
infections in this study, few women confirmed symptoms
when probed. Complaints of vaginal discharge were elic-
ited from 119 (17%) of the women and lower abdominal
pain from 58 (8%). Vaginal discharge was the most com-
mon clinical sign; candidalike discharge was found in 81
(12%) and other abnormal discharge was found in 227
(32%) of the women.
Factors associated with C trachomatis and/or N 
gonorrhoeae
Demographic, behavioural, and obstetric factors; symp-
toms, signs, and simple laboratory tests; and their associ-
ation with C trachomatis and/or N gonorrhoeae infection
are shown in Table 2. Age was the strongest predictor of
cervical infection. The prevalence of infection was highest
among teenagers (22%, 95% confidence interval (CI): 13
to 32), whereas two-thirds of the infections were within
the largest age group: women 20–29 years. None of the
evaluated symptoms predicted cervical infection. Symp-
toms of vaginal discharge or lower abdominal pain were
therefore not included in any of the risk scores. There were
65 (9%) women who reported believing that they had a
genital illness, but the prevalence of cervicitis was not sig-
nificantly higher in this group (OR = 1.6, 95% CI: 0.8 to
3.4). Of clinical findings, vaginal (excluding candida-like)
discharge was significantly associated with increased prev-
alence of cervicitis (OR = 1.8, 95% CI: 1.1 to 3.0). Several
discharge characteristics (thin, smelly, foamy and
increased amounts) were also significantly associated
with cervical infection. Two laboratory results were associ-
ated with cervicitis; white blood cells in the cervical smear,
and infection with T vaginalis.
The factors which were independently associated with cer-
vical infection are shown in Table 3.
Table 1: Three levels of risk scores: Variables included and their respective weights
Variables included Sociodemographic score Clinical score Microscopy score
Weight* Weight Weight
Sociodemographic factors
Age <20 21 24 24
20–29 13 14 14
30+ 0 0 0
Education Primary school 10 12 11
Junior secondary school 6 7 6
Senior secondary or higher 0 0 0
Length of relationship 1 year or less 5 - -
Between 1 and 2 years 2 - -
2 years and more 0 - -
Marital status Unmarried 12 - -
Married 0 - -
Clinical factors
Amount of discharge Moderate/profuse - 2 2
Scarce - 0 0
Thin/runny discharge Yes - 8 8
No - 0 0
Smelly discharge Yes - 5 4
No - 0 0
Cervix abnormal Yes - 3 2
No - 0 0
Microscopy results
White blood cell count in cervical smear 3–4+ - - 14
2+ - - 10
1+ - - 7
No/few - - 0
Cut-off at 40% sensitivity Score >32 Score >28 Score >36
Cut-off at 70% sensitivity Score >30 Score >21 Score >29
*The log of the OR from the correspondent multiple logistic regression analysis for each of the variables, multiplied by 10 and rounded to the 
nearest whole numberBMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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Table 2: Univariate analyses on risk factors for cervicitis (C trachomatis and/or N gonorrhoeae) among 703 antenatal care attendees in 
Gaborone, Botswana




< 20 76 17 (22) 9.1 3.4–24.1 0.000
20–29 432 44 (10) 3.6 1.5–8.5 0.004
30+ 195 6 (3) 1
Education
Primary school or less 168 17 (10) 1
Junior secondary school 310 36 (12) 1.2 0.6–2.2 0.620
Senior secondary or higher 225 14 (6) 0.6 0.3–1.2 0.160
Marital status
Married 114 2 (2) 1
Unmarried 589 65 (11) 6.9 1.7–28.7 0.008
Partners last 12 months
One partner 671 64 (10) 1
Two or more 32 3 (9) 1.0 0.3–3.3 0.976
Time in relationship
One year or less 118 19 (16) 2.5 1.4–4.6 0.003
1 to 2 years 137 16 (12) 1.7 0.9–3.2 0.094
>2 years 448 32 (7) 1
Subjective symptoms
Vaginal discharge
No 584 55 (9) 1
Yes 119 12 (10) 1.1 0.6–2.1 0.822
Lower abdominal pain
No 650 63 (10) 1
Yes 53 4 (8) 0.8 0.3–2.2 0.610
Thinks she has an infection
No 638 58 (9) 1
Yes 65 9 (14) 1.6 0.8–3.4 0.217
Clinical signs
Vaginal discharge
Negative 476 37 (8) 1
Positive 227 30 (11) 1.8 1.1–3.0 0.023
Candida-like discharge
Negative 622 61 (10) 1BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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Positive 81 5 (6) 0.6 0.2–1.5 0.279
Moderate or profuse discharge
Negative 447 34 (8) 1
Positive 256 33 (13) 1.8 1.1–3.0 0.023
Yellow discharge
Negative 438 38 (9) 1
Positive 265 29 (11) 1.3 0.8–2.2 0.322
Thin/runny discharge
Negative 615 48 (8) 1
Positive 88 19 (22) 3.3 1.8–5.9 0.000
Foamy discharge
Negative 590 1
Positive 113 19 (17) 2.3 1.3–4.1 0.005
Smelly discharge
Negative 659 58 (9) 1
Positive 44 9 (21) 2.7 1.2–5.8 0.014
Cervical bleeding/erythroplaquia
Negative 520 45 (9) 1
Positive 183 22 (12) 1.4 0.8–2.5 0.184
Laboratory analyses
Urine stix (nitritis/leucocytes)
Negative 609 59 (10) 1
Positive 94 8 (9) 0.9 0.4–1.9 0.718
WBC in cervical smear
None/few 124 5 (4) 1
1+ 267 22 (8) 2.1 0.8–5.8 0.135
2+ 171 18 (11) 2.8 1.0–7.8 0.048
3–4+ 140 22 (16) 4.4 1.6–12.1 0.004
Candida (microscopy or culture)
Negative 287 26 (9) 1
Positive 416 41 (10) 1.1 0.7–1.8 0.724
Trichomoniasis
Negative 571 41 (7) 1
Positive 132 26 (20) 3.2 1.9–5.4 0.000
Bacterial vaginosis (BV)
Negative 435 40 (9) 1
Positive 268 27 (10) 1.1 0.7–1.9 0.700
Table 2: Univariate analyses on risk factors for cervicitis (C trachomatis and/or N gonorrhoeae) among 703 antenatal care attendees in 
Gaborone, Botswana (Continued)BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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Syndromic management and screening for cervical 
infections
The sociodemographic, clinical, and microscopy-based
risk scores performed similar in the management of N
gonorrhoeae and C trachomatis infection, as illustrated with
their ROC-curves (Figure 1). The diagnostic accuracy of
the risk scores did not increase significantly when detailed
information from the clinical examination and subse-
quently the microscopy results were added to the sociode-
mographic risk factors.
Table 4 presents the evaluated options for the diagnosis of
C trachomatis and N gonorrhoeae in antenatal care in the
absence of specific diagnostic tests: the syndromic algo-
rithm, symptoms, signs, and the three risk scores. The VDS
algorithm did not identify women with C trachomatis and
N gonorrhoeae in our study population (positive likeli-
hood ratio (LR+) 1.1, 95% CI: 0.6 to 1.9). Symptoms of
vaginal discharge or lower abdominal pain in pregnancy
proved inappropriate as an entry point to the VDS algo-
rithm, with a LR+ of 0.94 (95% CI: 0.6–1.5). The current
practice of clinical screening for signs of vaginal discharge
(excluding candida-like discharge) also had low discrimi-
native ability (LR+ 1.5, 95 % CI 1.1–1.9).
All risk scores suffered from the choice between low sen-
sitivity and low specificity. With a cut-off taken at an
acceptable sensitivity of minimum 0.7, the risk score
based on sociodemographic factors identifies 50 (75%)
and misses 17 (25%) of the 67 cervical infections. Per true
case treated, six pregnant women would be prescribed
multiple antibiotic regimens unnecessarily. With a cut-off
at a sensitivity of 0.4, the sociodemographic risk score
identifies only 29 (43%) of the cervical infections. The
majority of the cervical infections would remain
untreated, and although over-treatment is reduced, four
pregnant women would still be unnecessary treated with
multiple antibiotics per infected women. The more com-
prehensive clinical and microscopy risk scores show simi-
lar results.
Discussion
Pregnant women are usually considered to be a low-risk
population, but among antenatal care attendees in Bot-
swana, the burden of reproductive tract infections is very
high. The prevalence of cervical infections is 10%, and
most of the infected women go undetected through nor-
mal antenatal care services. Published studies of STIs
among pregnant women in other countries in sub-Saha-
ran Africa show similar trends in the prevalence of cervical
infections. In our study, 8% have a C trachomatis infection,
compared to rates between 6% in Tanzania and 13% in
Cape Verde [13,22]. Gonorrhea is found in 3% of the
women, compared to rates that range from 2% in Gabon
to 8% in South Africa [16,21]. Although difficult to meas-
ure, it is likely that complications and sequelae due to
these infections among pregnant women and their infants
in sub-Saharan Africa are substantial.
Syndromic approach
Elicited symptoms of increased discharge or lower
abdominal pain are not predictive of cervical infection in
antenatal attendees in Botswana. These symptoms are
non-specific; they are common in pregnancy, and their
association with cervical infections is even lower among
pregnant than among non-pregnant women [23]. The
Table 3: Univariate and multiple logistic regression analysis of risk factors for cervicitis (C trachomatis and/or N gonorrhoeae) among 
703 antenatal care clients in Gaborone, Botswana
Total women Women with cervicitis Multiple logistic regression
No. (%) No. (%) Odds ratio p-value
Age groups
<20 76 (11) 17 (22) 10.5 (3.59–30.72) 0.000
20–29 432 (62) 44 (10) 4.0 (1.60–10.10) 0.003
30+ 195 (28) 6 (3) 1
Education
Primary school or less 168 (24) 17 (10) 1
Junior secondary school 310 (44) 36 (12) 0.6 (0.31–1.23) 0.168
Senior secondary or higher 225 (32) 14 (6) 0.4 (0.16–0.80) 0.013
Thin/runny discharge
No 615 (87) 48 (8) 1
Yes 88 (13) 19 (22) 2.1 (1.06–4.24) 0.035
WBC in cervical smear
None/few 124 (18) 5 (4) 1
1+ 267 (38) 22 (8) 2.0 (0.72–5.52) 0.188
2+ 171 (24) 18 (11) 2.7 (0.92–7.61) 0.070
3–4+ 140 (20) 22 (16) 3.7 (1.31–10.66) 0.014BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
Page 8 of 11
(page number not for citation purposes)
Receiver Operating Characteristics (ROC) curves for three levels of risk scores (sociodemographic, clinical and microscopy  risk scores) Figure 1
Receiver Operating Characteristics (ROC) curves for three levels of risk scores (sociodemographic, clinical and microscopy 
risk scores). The risk scores are based on multiple logistic regression analyses and used as a screening tool to identify N gonor-



















___ Sociodemographic risk score. Area under the curve 0.71 (0.65 to 0.78)
Risk factors included: Age, education, marital status, length of time in current relationship 
___ Clinical risk score. Area under the curve 0.73 (0.67 to 0.79)
Risk factors included: Age, education, specific clinical signs 
___ Microscopy risk score. Area under the curve 0.74 (0.68 to 0.80)
Risk factors included: Age, education, specific clinical signs and microscopy results of  
cervical smearBMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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VDS algorithm is used extensively to diagnose cervical
infections in antenatal care in Botswana [24], but our
results show that this management is no better than ran-
dom treatment.
To use the genital examination at the first antenatal care
visit as a clinical screening tool for cervical infections is
also unadvisable. According to the newly revised VDS
algorithm in Botswana, symptoms or signs of yellow dis-
charge are risk factors which should lead to treatment for
cervical infections. In our study among antenatal care
attendees, neither symptoms nor signs of yellow discharge
are associated with cervical infection. In pregnancy, symp-
toms or signs of vaginal discharge in general, yellow dis-
charge, or other specific discharge characteristics should
not be used as criteria for treating C trachomatis and N gon-
orrhoeae.
Other studies from sub-Saharan Africa conclude that case
management with the vaginal discharge syndrome has
poor discriminatory ability in the diagnosis of cervicitis
[25-27]. Several reviewers [28-30] emphasise that the syn-
dromic approach should not be used as a screening tool
for N gonorrhoeae and C trachomatis. Our study concurs
with a substantial body of knowledge indicating that the
syndromic approach should be used neither as a case
management of symptomatic women nor as a clinical
screening tool to identify C trachomatis and N gonorrhoeae
in antenatal care attendees in sub-Saharan Africa.
Screening strategies
Despite extensive analyses, all computed risk scores were
of limited value as screening tools in antenatal care
attendees. They had poor discriminative ability, even in
the study population in which they were computed and
adapted to under optimal conditions. As the syndromic
approach, the risk scores also resulted in a large number
of undetected cervical infections and substantial over-
treatment. Additionally, notification and treatment of sex-
ual partners, an essential element of STI management, is
difficult to justify when the majority of the identified
women do not have an STI [8]. A substantial improve-
ment of the management of cervical infections in antena-
tal care in developing countries seems impossible without
specific diagnostic tests.
The development of simple, rapid tests for C trachomatis
and N gonorrhoeae has been a high priority since the 1990s
[9-11]. Major progress has recently been made, and sev-
eral tests for C trachomatis and N gonorrhoeae are now on
the market [7,32]. The Sexually Transmitted Diseases
Diagnostics Initiative at the WHO has begun a pro-
gramme to field test and systematically evaluate these sim-
ple, affordable rapid tests [32,33]. So far, available tests
are found to be specific (>90%), but with a variable sensi-
tivity (25–85%) [34-36]. In Botswana, the health system
is relatively well functioning, and this country could well
serve as an exploratory site for the use of rapid tests for C
trachomatis and N gonorrhoeae. Through the prevention of
mother-to-child transmission of HIV programme, all
health posts and clinics have lay workers who perform
rapid tests for HIV. Simple tests for cervical infections per-
formed by clinicians or lay workers may prove a feasible
contribution to the improvement of diagnosis and the
reduction of the disease burden of these conditions in this
and similar settings.
Consistent with established knowledge on STI epidemiol-
ogy [6,31], youth is the single factor most strongly associ-
ated with C trachomatis and/or N gonorrhoeae in our study
Table 4: Diagnostic strategies to identify infection with Chlamydia trachomatis and/or Neisseria gonorrhoeae in 703 antenatal care 
attendees in Botswana.
Positive on assessment Cervical infection Sensitivity Specificity LR+* LR- PPV NPV
n (%) N (%)
Symptoms and signs
VDS algorithm 104 (15) 11 (11) 0.16 0.85 1.12 (0.63–1.92) 0.98 0.11 0.91
Symptoms alone: VD and/or LAP 155 (22) 14 (9) 0.21 0.78 0.94 (0.57–1.49) 1.02 0.09 0.90
Signs alone: VD (excl. candidiasis) 227 (32) 30 (13) 0.45 0.69 1.45 (1.06–1.89) 0.78 0.13 0.92
Risk scores†, sensitivity minimum 0.7
Sociodemographic risk score 327 (47) 50 (15) 0.75 0.56 1.71 (1.42–1.99) 0.45 0.15 0.96
Clinical risk score 372 (53) 54 (15) 0.81 0.50 1.61 (1.37–1.83) 0.39 0.15 0.96
Microscopy risk score 273 (39) 51 (19) 0.76 0.65 2.18 (1.80–2.55) 0.37 0.19 0.96
Risk scores, sensitivity minimum 0.4
Sociodemographic risk score 156 (22) 29 (19) 0.43 0.80 2.17 (1.55–2.91) 0.71 0.19 0.93
Clinical risk score 117 (17) 29 (25) 0.43 0.86 3.13 (2.20–4.30) 0.66 0.25 0.94
Microscopy risk score 116 (17) 29 (25) 0.43 0.86 3.16 (2.22–4.34) 0.66 0.25 0.94
LR+ = positive likelihood ratio; LR- = negative likelihood ratio; PPV = positive predictive value; NPV = negative predictive value; VDS = vaginal discharge syndrome;
LAP = lower abdominal pain; VD = vaginal discharge
* The positive likelihood ratios are calculated with 95% confidence interval.
†Risk factors included in each risk score are described in Table 1BMC Infectious Diseases 2007, 7:27 http://www.biomedcentral.com/1471-2334/7/27
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population. Thus age can be useful as a screening tool in
the traditional sense, to minimise the number of standard
diagnostic tests by identifying people with a higher-than-
average prevalence of infection [29]. If it were decided in
Botswana to introduce screening for cervical infections
with rapid tests in the antenatal care, selective screening of
younger women should be considered.
Conclusion
Although the vaginal discharge syndrome does not dis-
criminate between infected and uninfected women, the
algorithm is in extensive use to diagnose and treat C tra-
chomatis and N gonorrhoeae among antenatal care attend-
ees in Botswana. Unfortunately, risk scores do not appear
to improve the management of cervical infections in preg-
nancy substantially. To diagnose and treat asymptomatic
cervical infections, and to reduce the massive overtreat-
ment in the syndromic management, specific diagnostic
tests are necessary. Screening for cervical infections in
pregnant women is an essential public health measure,
and rapid tests will hopefully be available in developing
countries within a few years. In the temporary absence of
such tests, health authorities in sub-Saharan Africa should
consider reallocating their resources to other STI measures
rather than diagnosing and treating gonorrhoea and
chlamydia inadequately in antenatal care.
Abbreviations
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